The Magnetom Skyra established the standard for clinical 3T imaging in academic and high-volume outpatient environments for much of the past decade. Its 70-centimeter bore at full 3T field strength, combined with a Tim (Total imaging matrix) RF architecture, made it the default answer when a facility needed both field strength and patient tolerance in the same system. That installed base translates directly into one of the strongest refurbished markets for any MRI platform, and practices that cannot justify new Vida pricing often find that a refurbished Skyra closes the gap between clinical requirements and available capital. We finance Skyra acquisitions at both ends of that spectrum, new systems where they are still available and refurbished units from certified sources.
Understanding the Skyra as a financing project requires working through the same full scope as any 3T installation. The magnet itself represents the largest line item, but RF shielding for a 3T environment, dedicated chiller infrastructure, and the siting work associated with a 70-centimeter bore of substantial weight and electromagnetic sensitivity add meaningfully to total project cost. We structure Skyra financings that cover all of those components in a single package, funded in one to two weeks from a complete application.
The Skyra in Clinical and Financial Context
The Skyra's gradient performance, at 45 mT/m and 200 T/m/s slew rate in its standard configuration, supports the full range of clinical protocols that drove 3T adoption in the 2010s, including diffusion tensor imaging, functional MRI for pre-surgical planning, and high-resolution musculoskeletal work. These specifications remain clinically relevant, which is why the Skyra continues to command strong resale value even as the Vida and newer BioMatrix platforms have emerged. For a practice making a long-term investment decision, a refurbished Skyra in good condition can deliver a decade of productive clinical service at a cost well below a new system.
The software generation on a refurbished Skyra matters. Older software versions may lack current sequence options, and the cost of a software upgrade should be factored into the total acquisition cost when comparing options. We work with buyers to understand those post-purchase cost considerations and can often include upgrade costs in the financing package. A Skyra running current software and supported by an active service contract is a different financial asset than one running an obsolete platform, and we price those risk distinctions into the financing terms accordingly.
Practices That Finance the Skyra
Neurology clinics with high diffusion imaging volume, practices performing pre-surgical functional mapping, and centers where referring physicians have established 3T protocols for specific patient populations are natural Skyra buyers. The system's protocol depth and coil inventory, built over many years of clinical deployment, mean that a refurbished Skyra often comes with a more comprehensive accessory set than a newly released alternative platform. Physician-owned imaging facilities that want to own and control their imaging infrastructure find the refurbished Skyra market particularly attractive because the economics of ownership are more favorable than comparable new equipment at full 3T price points.
Academic institutions expanding departmental MRI capacity without the budget for new flagship systems have also been consistent Skyra buyers in the refurbished market. The research software options available for the Skyra are well-documented and the platform is familiar to technologist and physicist communities trained on it. For a facility where training time and protocol development represent real costs, buying into a familiar platform has operational value beyond the purchase price.
Timeline and Process for Skyra Financing
Skyra transactions typically follow one of two paths. For a refurbished system in the $500,000 to $1 million range, our process starts with the one-page application and the vendor's purchase agreement. We review the file and typically return a decision within 24 hours. The vendor's refurbishment documentation and OEM certification are part of that review and should accompany the application. Funding follows in one to two weeks from a complete package.
For larger projects involving new systems or extensive siting work, the additional documentation is three months of bank statements and a brief financial overview of the practice. This adds a few working days to the review but keeps the overall timeline well within industry norms. Practices evaluating a standard MRI equipment loan versus a lease structure for a Skyra acquisition benefit from running both scenarios before committing, since the tax treatment and balance sheet implications differ and the right answer depends on the specific practice's tax position and long-term equipment plan.
Comparing the Skyra to Other 3T Options
The Skyra sits in a competitive segment for 3T clinical imaging. The newer Magnetom Vida offers BioMatrix adaptive technology and current software but at a higher price point, while a refurbished GE Signa Architect represents an alternative 3T platform from a different manufacturer. Practices with existing Siemens service relationships often prefer to stay within the Siemens ecosystem for service cost and technologist continuity reasons, which makes the Skyra a natural default in the refurbished Siemens 3T market. Cross-manufacturer comparisons are reasonable when service infrastructure and training costs are factored into the total cost of ownership calculation.
Skyra Financing Questions
Start Your Magnetom Skyra Financing
New and refurbished Skyra financing available. Application-only up to approximately $400,000. B/C credit considered. Decisions typically within 24 hours. Submit your vendor quote and application to get started.